Amrutanjan Health Care Limited

BSE: 590006 NSE: AMRUTANJAN
Amrutanjan Health Care Limited - fmcg in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN L24231TN1936PLC000017 Incorporated 09 September 1936 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Listed - NSE: AMRUTANJAN · BSE: 590006 Public Limited Company FMCG
Market Cap
₹1,471 Cr
AMRUTANJAN · NSE
Share Price
₹508.45
-0.07% today
Revenue
₹187 Cr
FY 2015-16 · +12.1% YoY
EBITDA
₹30.78 Cr
Margin 16.5%
Net Profit
₹20.36 Cr
FY 2015-16 · +36.7% YoY
P/E (TTM)
46.2x
P/B 7.1x
ROE
20.2%
ROCE 31.4%
Debt / Equity
0.02
Interest cover 1.6x

About Amrutanjan Health Care Limited

Data last updated:

Amrutanjan Health Care Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 09 September 1936 and has been in existence for over 90 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN L24231TN1936PLC000017. Its GSTIN is 33AAACA3164C1ZE (Tamil Nadu). The company holds 19 GST registrations, of which 17 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 590006 and NSE: AMRUTANJAN.

The company has an authorised share capital of ₹5.1 Cr and a paid-up capital of ₹2.89 Cr. It was formerly known as The Venkulam Rubbers Limited and Amrutanjan Ltd. It is led by directors including Sambhuprasad Sivalenka (Managing Director) and Meenalochani Raghunathan.

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Chennai, Tamil Nadu.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹502.55 Cr, a growth of 11.2% compared to the previous year. For the same year it recorded a net profit of ₹64.18 Cr (net margin 12.8%) and EBITDA of ₹67 Cr (EBITDA margin 13.3%). The net worth stands at ₹370.23 Cr (up 13.4% YoY). Total assets are valued at ₹383.06 Cr (up 13.6% YoY).

The company has about 695 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Fruitnik and Amrutanjan Health Care. As per MCA filings, the company has satisfied charges of ₹43.5 Cr on record. Court records list 154 cases involving the company, including 96 filed by the company and 58 filed against it; 9 cases are pending. The company has 132 deals on record (126 market trades, 6 secondary share transfers); the latest was in August 2026. The company has 3 MSME Form 1 returns on record between 2023 and 2024, listing 16 overdue payments to 8 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amrutanjan.com.

Company details

CIN L24231TN1936PLC000017
Registration Number 000017
Incorporation Date 09 September 1936
ROC Chennai
Listing Status Listed - Listed on NSE (AMRUTANJAN); Listed on BSE (590006)
Company Status Active
Compliance Status Active Compliant

Name history

Amrutanjan Health Care has undergone 2 name changes throughout its history. The company was previously known as The Venkulam Rubbers Limited, and Amrutanjan Ltd. The current legal name is Amrutanjan Health Care Limited.

Company NameStatus
Amrutanjan Health Care LimitedCurrent
The Venkulam Rubbers LimitedPrevious
Amrutanjan LtdPrevious
Key People
Sambhuprasad Sivalenka Managing Director Meenalochani Raghunathan Director Swayambunathan Muralidharan Director

Contact details

Amrutanjan Health Care Limited's registered office is in Chennai, Tamil Nadu. Its website is amrutanjan.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    amrutanjan.com
  • Social Media
  • Registered Address
    No. 103 (Old No. 42 – 45), Luz Church Road, Chennai, Tamil Nadu, India – 600004
  • Industry
    FMCG, Personal Care & Skincare Products

To see the full contact details of Amrutanjan Health Care Limited, buy the company report.

Comprehensive company report
Amrutanjan Health Care Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Amrutanjan Health Care operates two associated brands: Fruitnik and Amrutanjan Health Care. Each brand links to its own profile.

BrandDescriptionWebsite
Fruitnik
Fruit juices are manufactured and marketed across South India.fruitnik.com
Amrutanjan Health Care
Manufacturer of ayurvedic healthcare productsamrutanjan.com

Business activity

The main business activity of Amrutanjan Health Care is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities

To see the full business activity and turnover split of Amrutanjan Health Care Limited, buy the company report.

Financials of Amrutanjan Health Care Limited

FY 2025-26 filings available

Amrutanjan Health Care Limited reported revenue of ₹502.55 Cr (up 11.2% YoY) for FY 2025-26.

Financial Highlights

FY 2015-16 · Consolidated
Revenue
₹187 Cr
+12.1% YoY
EBITDA
₹30.78 Cr
+30.5% YoY
Profit After Tax
₹20.36 Cr
+36.7% YoY
Net Worth
₹109 Cr
+14.5% YoY
Total Assets
₹112 Cr
+14.2% YoY
Total Debt
₹2.50 Cr
0.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2015-16FY 2014-15FY 2013-14FY 2012-13
Income statement
Revenue187167142138
Revenue growth+12.1%+17.5%+3.0%-
EBITDA30.7823.5921.8017.41
EBITDA margin+16.5%+14.2%+15.4%+12.7%
Profit before tax32.6724.1519.3715.47
Net profit20.3614.8913.029.92
Net profit margin+10.9%+8.9%+9.2%+7.2%
EPS (₹)13.299.507.976.42
Balance sheet
Total assets11298.4598.2598.30
Net worth10994.9589.2482.26
Total debt2.502.508.0015.12
Cash & bank48.2437.8935.2114.91
Net working capital75.0059.4859.0040.51
Cash flow
Cash from operations20.7018.3217.458.62
Cash from investing4.16(4.89)16.4913.49
Cash from financing(13.10)(11.93)(13.92)(14.26)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue503452421380406333261
Revenue growth+11.2%+7.3%+11.0%-6.5%+21.9%+27.3%-
EBITDA67.0058.3151.9244.5479.5774.8430.83
EBITDA margin+13.3%+12.9%+12.3%+11.7%+19.6%+22.5%+11.8%
Profit before tax77.8869.1361.9653.6590.5781.9034.45
Net profit64.1850.8344.8839.8267.1761.1225.08
Net profit margin+12.8%+11.3%+10.7%+10.5%+16.6%+18.4%+9.6%
EPS (₹)20.0317.5815.5613.6322.9920.938.58
Balance sheet
Total assets383337297300273223167
Net worth370327288291265216159
Total debt1.782.081.730.910.881.341.69
Cash & bank33.3283.1626.6170.3287.7513936.33
Net working capital16320622619219016687.33
Cash flow
Cash from operations35.9750.9027.9120.1852.2090.8718.18
Cash from investing(21.23)(30.97)19.17(2.48)(36.21)(87.76)(13.85)
Cash from financing(13.62)(13.49)(48.27)(14.99)(16.70)(7.42)(11.69)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue13510315014111894.05135123
Revenue growth (YoY)+14.9%+9.5%+10.6%+14.9%+7.1%+12.3%--
Other income3.023.814.734.124.304.434.824.36
Total expenses11298.7613211710185.6011899.40
EBITDA23.614.2117.9423.9216.538.4517.7023.35
EBITDA margin+17.5%+4.1%+12.0%+17.0%+14.0%+9.0%+13.1%+19.0%
Depreciation3.491.921.611.621.561.531.621.66
Interest0.040.040.050.050.050.050.040.06
Profit before tax23.106.0621.0126.3719.2211.3020.8625.99
Tax5.821.704.826.915.252.985.686.74

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 13 Nov 2026
ParticularsFY 2015-16FY 2014-15FY 2013-14FY 2012-13
Revenue187167142138
Revenue growth+12.1%+17.5%+3.0%-
Other income5.684.482.944.27
Total expenses156143120120
Employee cost28.5525.8722.8221.03
EBITDA30.7823.5921.8017.41
EBITDA margin+16.5%+14.2%+15.4%+12.7%
Depreciation3.353.213.603.73
Interest0.440.711.772.48
Profit before tax32.6724.1519.3715.47
Tax12.119.256.945.36
Net profit20.3614.8913.029.92
Net profit margin+10.9%+8.9%+9.2%+7.2%
EPS (₹)13.299.507.976.42
ParticularsFY 2015-16FY 2014-15FY 2013-14FY 2012-13
Equity & liabilities
Share capital2.922.922.922.92
Reserves & surplus10692.0386.3279.34
Shareholders' funds (net worth)10994.9589.2482.26
Minority interest0.000.000.000.00
Secured loans2.502.508.0015.06
Unsecured loans0.000.000.000.06
Total debt2.502.508.0015.12
Total liabilities11298.4598.2598.30
Assets
Gross block48.4940.4933.5746.74
Net block28.8224.0926.7629.98
Capital work in progress0.823.770.970.62
Investments8.999.109.1324.96
Inventories8.978.618.7210.24
Sundry debtors27.5927.6424.9728.25
Cash & bank balances48.2437.8935.2114.91
Loans & advances15.698.709.349.98
Total current assets10082.8478.2463.38
Total current liabilities25.4923.3619.2422.87
Net working capital75.0059.4859.0040.51
Total assets11298.4598.2598.30
ParticularsFY 2015-16FY 2014-15FY 2013-14FY 2012-13
Opening cash30.6729.179.157.06
Net cash from operating activities20.7018.3217.458.62
Net cash from investing activities4.16(4.89)16.4913.49
Net cash from financing activities(13.10)(11.93)(13.92)(14.26)
Net change in cash11.761.4920.027.85
Closing cash48.2437.8935.2114.91
ParticularsFY 2015-16FY 2014-15FY 2013-14FY 2012-13
Growth
Sales growth+12.1%+17.5%+3.0%-
EBITDA growth+30.5%+8.2%+25.2%-
PBT growth+35.3%+24.7%+25.2%+9997.0%
Net income growth+36.7%+14.4%+31.3%-
Revenue CAGR (3Y)+10.7%---
EBITDA CAGR (3Y)+20.9%---
Profitability & leverage
Net income margin+11.0%+9.0%+8.8%+7.3%
Return on capital employed+31.4%+25.3%+21.5%+18.1%
Return on net worth+20.2%+16.2%+14.5%+12.7%
Debt / equity0.020.060.130.23
Long-term debt / equity0.000.000.000.04
Interest cover1.603.489.7318.13
Efficiency & per share
Fixed asset turnover4.404.723.713.14
Inventory turnover22.2720.1815.6912.40
Debtors turnover7.096.655.596.32
EPS (₹)13.299.507.976.42
Dividend per share (₹)3.853.503.203.00
Book value per share (₹)74.4064.9761.0656.29
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue13510315014111894.05135123
Revenue growth (YoY)+14.9%+9.5%+10.6%+14.9%+7.1%+12.3%--
Other income3.023.814.734.124.304.434.824.36
Total expenses11298.7613211710185.6011899.40
EBITDA23.614.2117.9423.9216.538.4517.7023.35
EBITDA margin+17.5%+4.1%+12.0%+17.0%+14.0%+9.0%+13.1%+19.0%
Depreciation3.491.921.611.621.561.531.621.66
Interest0.040.040.050.050.050.050.040.06
Profit before tax23.106.0621.0126.3719.2211.3020.8625.99
Tax5.821.704.826.915.252.985.686.74
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue503452421380406333261
Revenue growth+11.2%+7.3%+11.0%-6.5%+21.9%+27.3%-
Other income17.5717.6816.3514.5415.3811.328.32
Total expenses436394369335326258231
Employee cost63.7659.1047.6948.8148.2341.7039.36
EBITDA67.0058.3151.9244.5479.5774.8430.83
EBITDA margin+13.3%+12.9%+12.3%+11.7%+19.6%+22.5%+11.8%
Depreciation6.326.536.065.213.803.674.36
Interest0.370.330.250.220.580.590.34
Profit before tax77.8869.1361.9653.6590.5781.9034.45
Tax19.9718.3016.9713.8123.3920.719.37
Net profit64.1850.8344.8839.8267.1761.1225.08
Net profit margin+12.8%+11.3%+10.7%+10.5%+16.6%+18.4%+9.6%
EPS (₹)20.0317.5815.5613.6322.9920.938.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital2.892.892.892.922.922.922.92
Reserves & surplus367324286288262213156
Shareholders' funds (net worth)370327288291265216159
Secured loans0.000.000.000.000.000.000.00
Unsecured loans1.782.081.730.910.881.341.69
Total debt1.782.081.730.910.881.341.69
Total liabilities383337297300273223167
Assets
Gross block88.7381.2475.2073.1047.8439.3039.04
Net block51.2549.4149.5348.9228.4623.2626.11
Capital work in progress10616.252.391.1117.331.570.00
Investments3.120.050.045.1712.8817.8418.21
Inventories37.3527.2628.9028.8326.0017.4623.72
Sundry debtors60.6455.8247.8933.0238.2617.6626.46
Cash & bank balances33.3283.1626.6170.3287.7513936.33
Loans & advances15712419212311542.6339.31
Total current assets289291296255267217126
Total current liabilities12684.1869.5962.5076.9051.4738.49
Net working capital16320622619219016687.33
Total assets383337297300273223167
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash10.163.714.902.192.917.2214.59
Net cash from operating activities35.9750.9027.9120.1852.2090.8718.18
Net cash from investing activities(21.23)(30.97)19.17(2.48)(36.21)(87.76)(13.85)
Net cash from financing activities(13.62)(13.49)(48.27)(14.99)(16.70)(7.42)(11.69)
Net change in cash1.126.44(1.19)2.72(0.72)(4.32)(7.36)
Closing cash33.3283.1626.6170.3287.7513936.33
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.2%+7.3%+11.0%-6.5%+21.9%+27.3%-
EBITDA growth+14.9%+12.3%+16.6%-44.0%+6.3%+142.8%-
PBT growth+12.7%+11.6%+15.5%-40.8%+10.6%+137.7%-0.7%
Net income growth+26.3%+13.3%+12.7%-40.7%+9.9%+143.7%-
Revenue CAGR (3Y)+9.8%+3.6%+8.2%+13.2%+17.0%+14.8%+8.1%
EBITDA CAGR (3Y)+14.6%-9.8%-11.5%+13.1%+37.0%+38.5%+2.2%
Profitability & leverage
Net income margin+11.5%+11.3%+10.7%+10.5%+16.6%+18.4%+9.6%
Return on capital employed+24.2%+21.9%+20.8%+18.8%+36.8%+42.3%+21.9%
Return on net worth+18.4%+16.5%+15.5%+14.3%+28.0%+32.6%+16.4%
Debt / equity0.010.010.000.000.000.010.01
Long-term debt / equity0.000.010.000.000.000.000.00
Interest cover0.610.640.550.560.770.831.28
Efficiency & per share
Fixed asset turnover5.915.785.686.289.318.507.09
Inventory turnover15.5616.0914.5913.8518.6816.1713.65
Debtors turnover8.638.7110.4110.6514.5215.098.81
EPS (₹)20.0317.5815.5613.6322.9920.938.58
Dividend per share (₹)4.904.604.604.604.604.202.10
Book value per share (₹)128.06112.9799.7899.4790.7073.7554.54

To see the full year-wise statements and ratios of Amrutanjan Health Care Limited, buy the company report.

Board of directors of Amrutanjan Health Care Limited

Amrutanjan Health Care has 6 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Meenalochani RaghunathanDirector12 Aug 20224 Years 3 MonthsCurrent
Sambhuprasad Sivalenka
Also directs: Goodhealth Holdings Private Limited
Managing Director01 Apr 200917 Years 7 MonthsCurrent
Swayambunathan MuralidharanDirector29 Jun 20215 Years 4 MonthsCurrent
Nagaraj Viswanathan
Also directs: Ananta Medicare Limited
Director13 Aug 20242 Years 3 MonthsCurrent
Ramaa Prabhakar Arikirevula
Also directs: Quiver Life Sciences Private Limited, Supra Sciences Private Limited
Director30 Jun 20233 Years 4 MonthsCurrent
Ramaswami KrishnanDirector08 May 20260 Years 6 MonthsCurrent
View all directors

Auditor

Amrutanjan Health Care Limited is audited by B S R & Co. LLP for the financial year 2025.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2025101248W/W-100022

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 46.50%, foreign institutional investors hold 2.40%, domestic institutional investors hold 12.30% and retail and other public shareholders hold 38.80%.

Promoters: 46.50%DII (Domestic Institutional): 12.30%FII (Foreign Institutional): 2.40%Retail & Others: 38.80%
Sep 2026
QUARTER
46.50% Promoters
12.30% DII (Domestic Institutional)
2.40% FII (Foreign Institutional)
38.80% Retail & Others
Promoter holding - history
Now 46.50% · Sep 2026High 46.50% · Dec 2025Low 46.50% · Dec 2025
45%45.8%46.5%47.3%48%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 46.50%Mar 2026: 46.50%Jun 2026: 46.50%Sep 2026: 46.50%46.50%46.50%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters46.50%46.50%46.50%46.50%
Public53.50%53.50%53.50%53.50%

Charges & borrowings

Open charges
None
Satisfied charges
₹43.5 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹20.50 Cr
Punjab National Bank₹7.50 Cr
Yes Bank Limited₹7.00 Cr
Standard Chartered Bank₹3.75 Cr
Ge Capital Services India₹2.00 Cr
Others₹2.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Dec 201110333658Yes Bank Limited₹3 CrSatisfied
08 Dec 201110333662Yes Bank Limited₹4 CrSatisfied
14 Jun 201110297315Hdfc Bank Limited₹20.5 CrSatisfied
01 Mar 200710038107The Tamil Nadu Industrial Investment Corporation Limited₹28 LakhSatisfied
16 Nov 200610026669The Tamil Nadu Industrial Investment Corporation Limited₹76 LakhSatisfied

To see the full charge records of Amrutanjan Health Care Limited, buy the company report.

Total charge records: 12 View all charges

Deals & funding

Amrutanjan Health Care Limited has 132 deals on record (126 market trades, 6 secondary share transfers); the latest was in August 2026.

Total deals
132
Market trades
126
Secondary share transfers
6

Deals on record (5 of 132)

WhenDealAmountParties
Jun 2023Market trade₹14.13 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Jun 2020Market trade₹20.26 CrBuyer: N.K.Securities, Graviton Research Capital LLP
Seller: N.K.Securities, Graviton Research Capital LLP
Nov 2014Market trade₹10.41 CrBuyer: N.K. Securities, Alphagrep Securities Private Limited
Seller: N.K. Securities, Alphagrep Securities Private Limited
Oct 2014Market trade₹5.03 CrBuyer: Alphagrep Securities Private Limited
Seller: Alphagrep Securities Private Limited
Sep 2014Market trade₹5.37 CrBuyer: Crosseas Capital Markets Private Limited
Seller: Crosseas Capital Markets Private Limited

To see the full deal history of Amrutanjan Health Care Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Amrutanjan Health Care Limited was last rated by Crisil on 02 Dec 2020.

Rating agencyRated onRating
Crisil02 Dec 2020

To see the full credit ratings and regulatory alerts of Amrutanjan Health Care Limited, buy the company report.

MSME payment delays

Amrutanjan Health Care Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 16 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 8)

SupplierAmount dueDue sinceReported on
an individual supplier
360Marcom Solutions Private Limited
Xpress Imprint Private Limited
an individual supplier
Air Calibre Systems

To see the full MSME payment records of Amrutanjan Health Care Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Amrutanjan Health Care Limited has a workforce of 695 employees on its EPFO records as of May 2026.

Employee count
695
Employee growth
7.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27695
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Amrutanjan Health Care Limited, buy the company report.

GST

Amrutanjan Health Care has 19 GST registrations: 17 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
19
Active
17
Cancelled / inactive
2
GSTINStateStatusRegistered on
33AAACA3164C1ZETamil NaduActive01 Jul 2017
33AAACA3164C2ZDTamil NaduActive27 Sep 2017
07AAACA3164C1Z9DelhiActive01 Jul 2017
09AAACA3164C1Z5Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Amrutanjan Health Care Limited, buy the company report.

Recent activity

Amrutanjan Health Care Limited has 29 board changes on record since 1989: 18 appointments and 11 cessations. The latest: Ramaswami Krishnan was appointed as Director on 08 May 2026.

Appointed
Ramaswami Krishnan was appointed as Director.
Filing
Amrutanjan Health Care Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chennai.
AGM
Amrutanjan Health Care Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Ceased
Govindan Raghavan ceased to be Director.
Ceased
Mahalingam Srinivasan ceased to be Company Secretary.
Appointed
Nagaraj Viswanathan was appointed as Director.
Appointed
Ramaa Prabhakar Arikirevula was appointed as Director.
Ceased
Sathyanarayana Pasumarthi Murthi ceased to be Director.
Ceased
Marie Shiranee Pereira ceased to be Director.
Ceased
Vydeeswaran Sambasivam ceased to be Director.
Appointed
Meenalochani Raghunathan was appointed as Director.
Appointed
Swayambunathan Muralidharan was appointed as Director.

49 earlier events are in the company report.

News

AMRUTANJAN: Q2 REVENUE 1.35B RUPEES VS 1.18B (YOY)
03 Nov 2026 · Exchange Update
AMRUTANJAN: Q2 SL NET PROFIT 173M RUPEES VS 139.6M (YOY)
03 Nov 2026 · Exchange Update
AMRUTANJAN: Q2 EBITDA 236M RUPEES VS 165.2M (YOY); Q2 EBITDA MARGIN 17.47% VS 14.04% (YOY)
03 Nov 2026 · Exchange Update

Frequently asked questions

Amrutanjan Health Care is an active public limited company based in Chennai, Tamil Nadu, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 09 September 1936 (90+ years old) and is registered under CIN L24231TN1936PLC000017. Listed on BSE: 590006 and NSE: AMRUTANJAN.

Amrutanjan Health Care reported revenue of ₹502.55 Cr for FY 2025-26 (up 11.2% YoY) based on standalone financials.

Amrutanjan Health Care has 6 current directors:

The latest financial statements of Amrutanjan Health Care on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Amrutanjan Health Care is 33AAACA3164C1ZE, registered in Tamil Nadu. The company has 19 GST registrations in all, of which 17 are active and 2 are cancelled or inactive. Other active GSTINs include 33AAACA3164C2ZD (Tamil Nadu), 07AAACA3164C1Z9 (Delhi), 09AAACA3164C1Z5 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Amrutanjan Health Care is L24231TN1936PLC000017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Amrutanjan Health Care is a listed company as per MCA records. Its shares are listed on both BSE (code: 590006) and NSE (symbol: AMRUTANJAN).

Amrutanjan Health Care has 154 court cases on record: 96 filed by the company and 58 filed against it. 9 are pending. Most are in the high courts.

Amrutanjan Health Care was incorporated on 09 September 1936, making it 90+ years old. It is registered with the Registrar of Companies, Chennai.

Amrutanjan Health Care has 132 deals on record (126 market trades, 6 secondary share transfers); the latest was in August 2026.

Ramaswami Krishnan was appointed as Director on 08 May 2026. Govindan Raghavan ceased to be Director on 23 Sep 2025. Mahalingam Srinivasan ceased to be Company Secretary on 31 May 2025. Amrutanjan Health Care has 29 board changes on record in total.